Julian Lord

Mr Lord has more than 15 years’ experience in the life science industry.

Before joining EM Imaging he was Group Financial Controller at Mereo BioPharma Group, working on establishing and growing the finance function and successful listings on AIM and NASDAQ.

Prior to Mereo, he was Head of Finance and Financial Controller at Immune Targeting Systems (ITS) Ltd from 2010 through to its merger with Vaxin Inc in 2015.

Mr Lord is also CFO for Caldan Therapeutics Ltd, a biotech company developing novel therapeutics targeting modulators of free fatty acid receptors for metabolic disease.

Mr Lord holds a BA (Hons) from Durham University and is a qualified management accountant (ACMA, CGMA).